Cohen Mh

672 citations
25 papers · 532 · h-index 14

Impact in

  • Oncology top 10%
    • Lung Cancer Research Studies
    • Vascular Tumors and Angiosarcomas
    • Peptidase Inhibition and Analysis
    • Sarcoma Diagnosis and Treatment
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Research Studies 3
    • Cancer Treatment and Pharmacology 2
    • Colorectal Cancer Treatments and Studies 2
    • Peptidase Inhibition and Analysis 2
    • Lung Cancer Treatments and Mutations 4
    • Sarcoma Diagnosis and Treatment 1

Cohen Mh

24 papers receiving 463 citations

Peers

Cohen Mh
Comparison fields: 5 of 76
  • Oncology 242
  • Pulmonary and Respiratory Medicine 220
  • Emergency Medical Services 29
  • Pathology and Forensic Medicine 64
  • Epidemiology 106
Replace Shingo Takanashi with:
Shingo Takanashi Japan
Y. Kenis Belgium
Monica Valente Italy
Michael Froehner Germany
Dianne M. Howser United States
Umut Kefeli Türkiye
Leila A. Kutteh United States
B Blomstedt Sweden
Gary B. Deutsch United States
Keishi Naruse Japan
Cohen Mh relative to Shingo Takanashi Japan Shingo Takanashi's profile →
Citations per field
00.5×1.7×
Shingo Takanashi · 1×
Citations per year

Countries citing papers authored by Cohen Mh

Since Specialization
Citations

This map shows the geographic impact of Cohen Mh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cohen Mh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cohen Mh more than expected).

Fields of papers citing papers by Cohen Mh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cohen Mh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cohen Mh. The network helps show where Cohen Mh may publish in the future.

Co-authors

The 25 scholars most cited alongside Cohen Mh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cohen Mh Line = papers co-authored together Cohen Mh links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Prospective randomized evaluation of the role of limb-sparing surgery, radiation therapy, and adjuvant chemoimmunotherapy in the treatment of adult soft-tissue sarcomas.
1978109
2
Small cell bronchogenic carcinoma: a distinct clinicopathologic entity.
197884
3
Hickman catheter clots: a common occurrence despite daily heparin flushing.
198734
4
Is thoracic radiation therapy necessary for patients with limited-stage small cell lung cancer? No.
198331
5
"Salvage" radiation therapy for intrathoracic small cell carcinoma of the lung progressing on combination chemotherapy.
198329
6
Studies on the clinical pharmacology and toxicology of isophosphamide (NSC-109724).
197628
7
Is immediate radiation therapy indicated for patients with unresectable non-small cell lung cancer? No.
198322
8
Signs and symptoms of bronchogenic carcinoma.
197422
9
Phase I clinical trial of weekly administration of 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside) (NSC-141540; VP-16-213).
197522
10
The role of the reticuloendothelial system in diffuse, low grade intravascular coagulation.
196622
11
Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
198519
12
Randomized trial of chlorpromazine, caffeine, and methyl-CCNU in disseminated melanoma.
198018
13
Cystic hypersecretory duct carcinoma of the breast. Report of a case with fine-needle aspiration.
198815
14
Immunologic monitoring in carcinoma of the breast.
197715
15
Natural history of lung cancer.
198213
16
An active chemotherapy regimen for squamous cell lung cancer.
19849
17
Models for the control of development.
19719
18
Phase I clinical trial of a single-dose and two weekly schedules of ICRF-159 (NSC-129943).
19747
19
Immunologic studies in American patients with Burkitt-like lymphoma.
19677
20
Phase I study of thalicarpine (NAC-68075), a plant alkaloid of noval structure.
19766

About Cohen Mh

Cohen Mh is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Molecular Biology and Pathology and Forensic Medicine, having authored 25 papers that have together received 532 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Research Studies (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Cancer Treatment and Pharmacology (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Peptidase Inhibition and Analysis (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (242 citations), Pulmonary and Respiratory Medicine (220 citations), Emergency Medical Services (29 citations), Pathology and Forensic Medicine (64 citations) and Epidemiology (106 citations). Cohen Mh has collaborated with scholars based in United States. Frequent co-authors include Matthews Mj, Murray F. Brennan, Richard Simon, B A Chabner, Rosenberg Sa, Claudia A. Seipp, H Kent, Robert C. Young, José Costa and DC Ihde. Their work appears in journals such as PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact